Logo Image
News
All NewsDosing & Delivery InnovationsPress ReleasesProduct Approvals and Launches
Watch
Expert ConversationsNews & AnalysisShows & Podcasts
Journals
All JournalsThe American Journal of Managed CarePopulation Health, Equity & OutcomesEvidence-Based OncologyAbout Supplements and Featured PublicationsSupplements and Featured Publications IssuesSubmit a Manuscript
Conferences
Conference CoverageConference ListingPost Conference Perspectives
More
Events
AJMC EventsEvents CalendarInstitute for Value-Based MedicinePatient-Centered Oncology CarePopulation Health RoundtablesWebinars
Resources
Interactive ToolsFormulary CentralClinical SpotlightMicrositesSponsored Content
CE
About AJMC
AJMC StaffAnniversarySeema Sonnad AwardStrategic Alliance Partners

Subscribe

  • News
  • Watch
  • Journals
  • Conferences
  • Events
  • Resources
  • CE
  • About AJMC
  • Subscribe
  • Biosimilars
  • Cardiorenalmetabolic
    • Cardiomyopathy
    • Cardiovascular
    • Chronic Kidney Disease
    • Diabetes
    • Heart Failure
    • Type 1 Diabetes
  • Dermatology
    • Alopecia
    • Atopic Dermatitis
    • Chronic Hand Eczema
    • Psoriasis
  • Gastroenterology
  • Hematology
    • ALL/AML
    • CLL/SLL
    • GVHD
    • Hemophilia
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myelodysplastic Syndromes
    • Myeloproliferative Neoplasms
    • Non-Hodgkin Lymphoma
    • Rare Blood
  • Hepatology
    • Hepatitis
    • Liver
    • MASH
  • Immunology
    • Allergy
    • Autoimmune
    • Inflammation
    • Lupus
    • Myasthenia Gravis
    • Rheumatoid Arthritis
  • Infectious Disease
    • COVID-19
    • HIV
    • RSV
    • Vaccines
  • Mental Health
    • Major Depressive Disorder
    • Sleep
  • Neurology
    • Duchenne Muscular Dystrophy
    • Epilepsy
    • Multiple Sclerosis
    • Parkinson Disease
  • Obesity
  • Oncology
    • Breast Cancer
    • Cholangiocarcinoma
    • Colorectal Cancer
    • Immuno-Oncology
    • Liver Cancer
    • Non–Small Cell Lung Cancer
    • Ovarian Cancer
    • Prostate Cancer
    • Skin Cancer
    • Small Cell Lung Cancer
    • Soft Tissue Sarcoma
  • Ophthalmology
  • Pulmonology
    • COPD
    • Pulmonary Arterial Hypertension
  • Rare Disease
    • Spinal Muscular Atrophy
  • Respiratory
    • Asthma
    • Pulmonary Fibrosis
  • Rheumatology
  • Urology
    • Overactive Bladder
  • Women's Health
    • Endometriosis
  • Biosimilars
  • Bispecifics Network
  • Center on Health Equity & Access
  • Digital Health
  • Dosing & Delivery Innovations
  • Formulary
  • Gene Therapy
  • Guidelines
  • Health Care Administration
    • Employers
    • Medicare
    • Reimbursement
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Population Health
  • Product Approvals and Launches
  • Technology
  • Value-Based Care
Spotlight -
Free In-Person Regional Events Focused on Oncology and Population Health
Advertisement
|Videos|February 3, 2022

MRD and Value-Based Care Models

Dr Patel describes the importance of MRD in value-based care models.

Advertisement

Episodes in this series

EP. 1 Explaining Molecular Residual Disease
EP. 1 Explaining Molecular Residual Disease
EP. 2 The Evolution of Circulating Tumor DNA in Oncology
EP. 2 The Evolution of Circulating Tumor DNA in Oncology
EP. 3 MRD Assessments
EP. 3 MRD Assessments
EP. 4 MRD Results and Guiding Treatment Decisions
EP. 4 MRD Results and Guiding Treatment Decisions
EP. 5 MRD and Value-Based Care Models
Now Playing
EP. 5 MRD and Value-Based Care Models
EP. 6 Supporting MRD Availability
EP. 6 Supporting MRD Availability
EP. 7 INSPIRE and IMvigor011 Trials
EP. 7 INSPIRE and IMvigor011 Trials
EP. 8 Potential Changes for MRD in the Future
EP. 8 Potential Changes for MRD in the Future
Advertisement
News Network
|
Video Series
|
Clinical
|
Guiding Appropriate Cancer Treatment with Molecular Residual Disease Testing

Related Content

Advertisement
spleen and liver | Image credit: RFBSIP - stock.adobe.com

Selinexor Shows Modest Spleen Response in JAK Inhibitor–Refractory MF

BySkylar Jeremias
August 31st 2026
Expert featured in this series.

New Registry Data on MAC Pulmonary Disease Outcomes

ByAshley Losier, MD
Published: August 31st 2026 | Updated: August 31st 2026
Expert featured in this series.

Top Unmet Needs in MAC Pulmonary Disease Management

ByAshley Losier, MD
Published: August 31st 2026 | Updated: August 31st 2026
DLBCL | Image:  Marshall Kadin/ASH Image Bank

20 Years of ADC Trials in Lymphoma Leave Many Questions Unanswered, Authors Say

August 30th 2026
Helen Nde, MPH

What It Will Take to Advance Hepatitis B Elimination: Helen Nde, MPH

ByBrooke McCormick,Helen Nde, MPH,Laura Joszt, MA
August 30th 2026
Advertisement
Advertisement

Trending on AJMC

1

FDA Expands Tirzepatide Label to Reduce Cardiovascular Risk in Type 2 Diabetes

2

DOJ Abandons Olmstead Defense as Texas v Kennedy Advances

3

Myasthenia Gravis Linked to Greater Longevity Than Multiple Sclerosis

4

FDA Approves Rusfertide to Treat Erythrocytosis In Polycythemia Vera

5

FDA Approves Brepocitinib as First Oral Drug for Dermatomyositis

Brand Logo
  • About
  • Contact
  • Editorial Boards
  • Advertise
  • Do Not Sell My Information
  • Terms & Conditions
  • Privacy Policy

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2026 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text